b. pharmaconsult ApS: Financial statements 2021
CVR: 38310232
Source: annual report 2021, Danish Business Authority
01/07/2020 – 30/06/2021
b. pharmaconsult ApS (CVR 38310232) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -73,270 and a net result of DKK -308,775 compared with DKK 146,360 the year before. Equity in the 2021 report amounted to DKK 45,936. The solvency ratio was 23%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -73,270
- Profit/Loss
- DKK -308,775
- Equity
- DKK 45,936
- Total Assets
- DKK 199,699
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | -73K | -309K | 46K | 1 |
| 2020 | 2.1M | 1.6M | 146K | 410K | 2 |
| 2019 | 2.5M | 1.7M | -9K | 318K | 2 |
Official annual report
Find more companies like b. pharmaconsult ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
On October 13, 2021, the company changed its name from b. pharmaconsult IVS to b. pharmaconsult ApS.
About b. pharmaconsult ApS
b. pharmaconsult ApS was a Danish company of the type Anpartsselskab based in Gentofte, founded in 2017. The company has been dissolved on 1 March 2024. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named b. pharmaconsult IVS. The company has 1 employee (2020). In 2021, the company reported a gross profit of DKK -73,270 and a net result of DKK -308,775 compared with DKK 146,360 the year before. Equity in the 2021 report amounted to DKK 45,936.